4.0 Review

Amyloid fibrils Abnormal protein assembly

Journal

PRION
Volume 2, Issue 3, Pages 112-117

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/pri.2.3.7488

Keywords

fibril; beta-sheet; aggregation; Alzheimer's disease; fibre diffraction; ssNMR; small angle X-ray scattering

Funding

  1. BBSRC
  2. Alzheimer's research trust
  3. Royal Society
  4. Wellcome Trust

Ask authors/readers for more resources

Amyloid refers to the abnormal fibrous, extracellular, proteinaceous deposits found in organs and tissues. Amyloid is insoluble and is structurally dominated by beta-sheet structure. Unlike other fibrous proteins it does not commonly have a structural, supportive or motility role but is associated with the pathology seen in a range of diseases known as the amyloidoses. These diseases include Alzheimer's, the spongiform encephalopathies and type II diabetes, all of which are progressive disorders with associated high morbidity and mortality. Not surprisingly, research into the physicochemical properties of amyloid and its formation is currently intensely pursued. In this chapter we will highlight the key scientific findings and discuss how the stability of amyloid fibrils impacts on bionanotechnology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available